Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence

Abstract Single-photon emission-computed tomography (SPECT) after the administration of99m Tc-TRODAT-1 was performed on healthy subjects and subjects with methamphetamine (METH)dependence at time 1 (T1) after 24–48 h of abstinence, time 2 (T2) after 2 weeks of abstinence, and time 3 (T3) after 4 wee...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry research. Neuroimaging Vol. 221; no. 1; pp. 92 - 96
Main Authors Yuan, Jie, Lv, Rongbin, Robert Brašić, James, Han, Mei, Liu, Xingdang, Wang, Yuankai, Zhang, Guangming, Liu, Congjin, Li, Yu, Deng, Yanping
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 30.01.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Single-photon emission-computed tomography (SPECT) after the administration of99m Tc-TRODAT-1 was performed on healthy subjects and subjects with methamphetamine (METH)dependence at time 1 (T1) after 24–48 h of abstinence, time 2 (T2) after 2 weeks of abstinence, and time 3 (T3) after 4 weeks of abstinence. In contrast to values in controls, the values of the striatal DAT specific uptake ratios (SURs) in subjects with METH dependence were significantly lower at T1 ( n =25), T2 ( n =9), and T3 ( n =8); a mild increase in SURs was observed at T2 and T3, but values were still significantly lower than those in controls. In subjects with METH dependence, there was a trend for a negative correlation of striatal DAT SURs and craving for METH at T1. METH craving, anxiety and depression scores significantly decreased from T1 to T2 to T3. We conclude that Han Chinese people with METH dependence experience significant striatal DAT dysfunction, and that these changes may be mildly reversible after 4 weeks of abstinence, but that DAT levels still remain significantly lower than those in healthy subjects. The mild recovery of striatal DAT may parallel improvements in craving, anxiety and depression.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0925-4927
1872-7506
DOI:10.1016/j.pscychresns.2013.11.005